Pages that link to "Q50980787"

The following pages link to Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study (Q50980787):

Displaying 30 items.

• Mechanisms of granulin deficiency: lessons from cellular and animal models (Q26824221) (← links)
• Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage (Q36017101) (← links)
• Association Between Progranulin and Gaucher Disease (Q36102138) (← links)
• Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features (Q36535668) (← links)
• TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia (Q37154601) (← links)
• Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in southern Italy. (Q37248850) (← links)
• Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers. (Q37293615) (← links)
• The behavioral variant of frontotemporal dementia: linking neuropathology to social cognition (Q38078773) (← links)
• Presymptomatic studies in genetic frontotemporal dementia. (Q38135140) (← links)
• GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil. (Q38393604) (← links)
• How many biomarkers to discriminate neurodegenerative dementia? (Q38570242) (← links)
• Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia. (Q38667291) (← links)
• Imaging and fluid biomarkers in frontotemporal dementia. (Q38670219) (← links)
• Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic (Q38814847) (← links)
• Circulating progranulin as a biomarker for neurodegenerative diseases (Q39472371) (← links)
• Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol. (Q40895731) (← links)
• Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by GRN Mutations (Q41455989) (← links)
• Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy (Q43447667) (← links)
• Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point? (Q47271759) (← links)
• The Heritability of Frontotemporal Lobar Degeneration: Validation of Pedigree Classification Criteria in a Northern Italy Cohort. (Q47332372) (← links)
• Mendelian forms of disease and age at onset affect survival in frontotemporal dementia (Q47908840) (← links)
• Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study (Q47966141) (← links)
• Biomarkers in frontotemporal dementia (Q57911950) (← links)
• Next Generation Sequencing Analysis in Early Onset Dementia Patients (Q64236121) (← links)
• Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia (Q64268616) (← links)
• Partial deletions of the GRN gene are a cause of frontotemporal lobar degeneration (Q87174850) (← links)
• Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation (Q87359504) (← links)
• The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases (Q89745734) (← links)
• Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers (Q91781237) (← links)
• Genome Wide Association Study and Next Generation Sequencing: A Glimmer of Light Toward New Possible Horizons in Frontotemporal Dementia Research (Q92477950) (← links)